Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Sepsis - Pipeline Review, H2 2016 - Key Vendors are Adrenomed AG, Batu Biologics & Bristol-Myers Squibb Company - Research and Markets

Research and Markets
Posted on: 18 Nov 16

Research and Markets has announced the addition of the "Sepsis - Pipeline Review, H2 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Sepsis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Sepsis and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Mentioned:

  • Adrenomed AG
  • Altor BioScience Corporation
  • Am-Pharma B.V.
  • Arch Biopartners, Inc.
  • Aridis Pharmaceuticals LLC
  • Asahi Kasei Pharma Corp.
  • Astellas Pharma Inc.
  • Batu Biologics, Inc.
  • Biomedica Management Corporation
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Cell2B S.A.
  • Chiesi Farmaceutici SpA
  • Chiome Bioscience, Inc.
  • Cilian AG
  • Cognosci, Inc.
  • Cytheris SA
  • Endacea, Inc.
  • Evec, Inc.
  • Huons Co., Ltd.
  • (25+ Others)

Key Topics Covered:

  1. Introduction
  2. Sepsis Overview
  3. Therapeutics Development
  4. Pipeline Products for Sepsis - Overview
  5. Pipeline Products for Sepsis - Comparative Analysis
  6. Sepsis - Therapeutics under Development by Companies
  7. Sepsis - Therapeutics under Investigation by Universities/Institutes
  8. Sepsis - Pipeline Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Sepsis - Products under Development by Companies
  13. Sepsis - Products under Investigation by Universities/Institutes
  14. Sepsis - Companies Involved in Therapeutics Development

For more information about this report visit

View source version on

Business Wire

Last updated on: 18/11/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.